Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Oct;10(10):930-931.
doi: 10.1016/S2213-2600(22)00213-2. Epub 2022 Jun 7.

Early treatment to prevent progression of SARS-CoV-2 infection

Myron S Cohen  1
Affiliations
Comment

Early treatment to prevent progression of SARS-CoV-2 infection

Myron S Cohen. Lancet Respir Med. 2022 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

MSC is co-chair of the HIV Prevention Trials Network and COVID Prevention Network supported by National Institutes of Health research funding. In addition, the author serves on an advisory board for Aerium, Atea, and GSK.

Comment on

References

    1. Johns Hopkins University Coronavirus resource center. https://coronavirus.jhu.edu/map.html
    1. Montgomery H, Hobbs FDR, Padilla F, et al. Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised double-blind, placebo-controlled trial. Lancet Respir Med. 2022 doi: 10.1016/S2213-2600(22)00180-1. published online June 7. - DOI - PMC - PubMed
    1. Kompaniyets L, Pennington AF, Goodman AB, et al. Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020–March 2021. Prev Chronic Dis. 2021;18:E66. - PMC - PubMed
    1. Centers for Disease Control and Prevention Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlying-e... - PubMed
    1. Levin MJ, Ustianowski A, De Wit S, et al. Intramuscular AZD7442 (tixagevimab–cilgavimab) for prevention of COVID-19. N Engl J Med. 2022 - PMC - PubMed